United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
International Journal of Drug Policy 2022 Brian S. Barnett, Sloane E Parker, Jeremy Weleff 57 citations
Medicine is currently experiencing a "psychedelic renaissance", said by many to have commenced in 2006. Since then, clinical trials have consistently demonstrated promising findings for psychedelic-assisted therapies in the treatment of various mental health conditions and addictions. While most of this work has been privately funded, governmental biomedical research funding bodies in countries...